Repurposing Ivermectin for PKDL Treatment
Condition(s):Post-kala-azar Dermal LeishmaniasisLast Updated:February 9, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Post-kala-azar Dermal LeishmaniasisLast Updated:February 9, 2024Recruiting
Condition(s):OCDLast Updated:February 6, 2024Recruiting
Condition(s):LeprosyLast Updated:January 24, 2024Recruiting
Condition(s):Environmental Enteric Dysfunction; Gut Microbiota DysbiosisLast Updated:January 17, 2024Recruiting
Condition(s):CholeraLast Updated:February 28, 2024Recruiting
Condition(s):Acute Watery DiarrhoeaLast Updated:December 22, 2023Completed
Condition(s):Feasibility; Acceptability of Health CareLast Updated:December 19, 2023Active, not recruiting
Condition(s):MigraineLast Updated:December 6, 2023Active, not recruiting
Condition(s):Blood Pressure; Pharmacy; Cost-effectivenessLast Updated:November 28, 2023Recruiting
Condition(s):PoliomyelitisLast Updated:November 18, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.